| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Revenue | $3.17B | +0.2% |
| Cost of Revenue | $2.11B | -1.6% |
| Gross Profit | $1.05B | +3.4% |
| R&D Expense | $50.4M | +4.6% |
| Operating Income | $158.1M | +34.2% |
| Interest Expense | $25.7M | -0.8% |
| Pre-tax Income | $134.2M | +25.3% |
| Income Tax | $13.5M | -48.1% |
| Net Income | $120.7M | +48.8% |
| EPS (Basic) | $1.02 | +50.0% |
| EPS (Diluted) | $1.02 | +50.0% |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $346.3M | +8.7% |
| Short-term Investments | $41.6M | — |
| Accounts Receivable | $323.1M | -4.5% |
| Inventory | $245.7M | +6.4% |
| Current Assets | $1.03B | +7.3% |
| Total Assets | $2.33B | +4.2% |
| Current Liabilities | $669.1M | +10.2% |
| Line Item | 2025-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $148.5M | -51.9% |
| Capital Expenditures | $47.1M | +0.0% |
| Investing Cash Flow | -$34.8M | -670.5% |
| Financing Cash Flow | -$84.0M | +2.2% |
| Free Cash Flow | $101.4M | -61.2% |
| Long-term Debt |
| $447.1M |
| +0.2% |
| Total Liabilities | $1.38B | +2.2% |
| Stockholders' Equity | $951.7M | +7.3% |